Lv7
4360 积分 2023-06-27 加入
Twenty years of induced pluripotent stem cells
1小时前
求助中
Realizing the potential of agonistic antibody immunotherapy
1小时前
已完结
纯合子家族性高胆固醇血症早期筛查与管理中国专家共识（2024年）
7天前
已完结
The evolving landscape of obesity pharmacotherapy
7天前
已完结
Trends in the landscape of clinical trials of innovative drugs in China since 2015
7天前
已完结
Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia
8天前
已完结
Anti-ANGPTL3 Antibody SHR-1918 for Homozygous Familial Hypercholesterolemia
9天前
已完结
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
11天前
已完结
A dose–response meta-analysis to evaluate the relationship between high-density lipoprotein cholesterol and all-cause and cardiovascular disease mortality
11天前
已完结
Fibroblast activation and heterogeneity in fibrotic disease
14天前
已完结
皖公网安备34019202002308
